Intuitive Surgical, Inc. (ISRG) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$451.38
Price Target
$622.60
Target Range
$525.00 — $750.00
Analyst Rating
Buy
Forward P/E43.6x
Trailing P/E57.4x
Forward PEG2.00
Implied Growth+24.9%
Median Target$618.00
Analyst Spread36.1%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$525
+16.3%
Consensus
$623
+37.9%
Bull Case
$750
+66.2%
Valuation Model TargetsConfidence: 80/100
Bear$446
Base$677
Bull$888
ISRG Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Intuitive Surgical, Inc. (ISRG) has a Wall Street consensus price target of $622.60, based on estimates from 55 covering analysts. With the stock currently trading at $451.38, this represents a potential upside of +37.9%. The company has a market capitalization of $160.32B.
Analyst price targets range from a low of $525.00 to a high of $750.00, representing a 36% spread in expectations. The median target of $618.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 38 analysts rating the stock as a Buy or Strong Buy,12 rating it Hold, and 5 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ISRG trades at a trailing P/E of 57.4x and forward P/E of 43.6x. The forward PEG ratio of 2.00 reflects a premium valuation. Analysts expect EPS to grow +24.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $677.29, with bear and bull scenarios of $445.56 and $887.62 respectively. Model confidence stands at 80/100, indicating high predictability in the company's fundamentals.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+42.7%
Avg Forward P/E58.4x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 SYKStryker Corporation | $113.1B | $295.25 | $403.69 | +36.7% | Buy | 19.7x | 50 |
 MDTMedtronic plc | $99.7B | $77.79 | $109.50 | +40.8% | Buy | 14.1x | 49 |
 BSXBoston Scientific Corporation | $83.2B | $55.98 | $91.33 | +63.1% | Buy | 16.6x | 43 |
 ZBHZimmer Biomet Holdings, Inc. | $16.3B | $83.01 | $97.90 | +17.9% | Hold | 9.8x | 42 |
 HOLXHologic, Inc. | $17.0B | $76.01 | $79.00 | +3.9% | Hold | 17.2x | 42 |
 NVCRNovoCure Limited | $1.8B | $15.88 | $33.50 | +111.0% | Buy | — | 15 |
 GMEDGlobus Medical, Inc. | $12.2B | $90.03 | $110.67 | +22.9% | Buy | 20.1x | 36 |
 ATRCAtriCure, Inc. | $1.5B | $29.44 | $50.67 | +72.1% | Buy | 392.5x | 19 |
 ABTAbbott Laboratories | $151.6B | $87.17 | $128.71 | +47.6% | Buy | 15.9x | 41 |
 JNJJohnson & Johnson | $543.6B | $225.59 | $249.27 | +10.5% | Buy | 19.5x | 40 |
Upside Potential Comparison
NVCRATRCBSXABTMDTSYKGMEDZBHFull ISRG Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy ISRG Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See ISRG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ISRG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ISRG vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonISRG — Frequently Asked Questions
Quick answers to the most common questions about buying ISRG stock.
What is the ISRG stock price target for 2026?
The consensus Wall Street price target for ISRG is $622.6, representing 37.9% upside from the current price of $451.38. With 55 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is ISRG a buy, sell, or hold?
ISRG has a consensus rating of "Buy" based on 55 Wall Street analysts. The rating breakdown is predominantly bullish, with 38 Buy/Strong Buy ratings. The consensus 12-month price target of $622.6 implies 37.9% upside from current levels.
Is ISRG stock overvalued or undervalued?
At a forward P/E of 43.636x, ISRG trades at a premium valuation. The consensus price target of $622.6 (37.9% upside) suggests analysts still see growth justifying the multiple.
How high can ISRG stock go?
The most bullish Wall Street analyst has a price target of $750 for ISRG, while the most conservative target is $525. The consensus of $622.6 represents the median expectation. Our quantitative valuation model projects a bull case target of $888 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover ISRG stock?
ISRG is heavily covered by Wall Street, with 55 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 38 have Buy ratings, 12 recommend Hold, and 5 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ISRG stock forecast?
The 12-month ISRG stock forecast based on 55 Wall Street analysts shows a consensus price target of $622.6, with estimates ranging from $525 (bear case) to $750 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $677, with bear/bull scenarios of $446/$888.
What is ISRG's fair value based on fundamentals?
Our quantitative valuation model calculates ISRG's fair value at $677 (base case), with a bear case of $446 and bull case of $888. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 80/100.
What is ISRG's forward P/E ratio?
ISRG trades at a forward P/E ratio of 43.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 57.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy ISRG stock?
Wall Street analysts are very optimistic on ISRG, with a "Buy" consensus rating and $622.6 price target (37.9% upside). 38 of 55 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ISRG price targets vary so much?
ISRG analyst price targets range from $525 to $750, a 36% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $622.6 consensus represents the middle ground. Our model's $446-$888 range provides an independent fundamental perspective.